{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-290823","form_type":"8-K","ticker":"NUVB","cik":"0001811063","company_name":"Nuvation Bio Inc.","filed_at":"2026-06-30T21:17:05+00:00","discovered_at":"2026-06-30T21:18:00.303066+00:00","generated_at":"2026-06-30T21:18:08.147533+00:00","sec_items":["1.01","8.01","1.02","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nuvation Bio closes $250M 0.75% convertible senior notes offering due 2032","bullets":["$250M aggregate principal of 0.75% Convertible Senior Notes due 2032; initial conversion price ~$7.84/share (35% premium).","Net proceeds ~$241.2M; used to repay $58.5M loan, pay $14.9M for capped call, remainder for general corporate.","Capped call transactions entered to reduce dilution; cap price $10.4580/share (80% premium).","Underwriters' 30-day option for additional $37.5M notes.","Prior loan agreement terminated upon full repayment of ~$58.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-290823","json":"https://secwatch.observer/filing/0001193125-26-290823.json","markdown":"https://secwatch.observer/filing/0001193125-26-290823.md","text":"https://secwatch.observer/filing/0001193125-26-290823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811063/000119312526290823/0001193125-26-290823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811063/000119312526290823/d81296d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T21:18:08.147533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}